4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-043288
Options or other derivatives
- EVP, Drug Development acquired 165,961 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANHARD KIMBERLY EVP, Drug Development | 2022-07-25 | Grant or award · Employee Stock Option (Right to Buy) | +165,961 | 165,961 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…